26 February 2021>: Clinical Research
Serum Progranulin As a Risk Predictor in Patients with Acute Myocardial Infarction
Ting Zhou 1ABCD , Yanjiong Chen 2B , Shihan Zhang 3F , Ming Li 4C , Jing Wang 2AEFG*DOI: 10.12659/MSM.928864
Med Sci Monit 2021; 27:e928864
Table 1 Baseline characteristics of the study participants.
Characteristics | Experiment (n=342) | Control (n=255) | P |
---|---|---|---|
Gender (M: F) | 240: 102 | 174: 81 | 0.611 |
Age (years) | 61.38±9.18 | 61.85±10.37 | 0.778 |
BMI (kg/m) | 24.92±3.03 | 24.18±2.43 | 0.285 |
Progranulin (ng/mL) | 145.19±11.10 | 134.38±13.99 | 0.0001 |
Glucose (mmol/L) | 4.98±2.27 | 4.43±0.49 | 0.106 |
Cholesterol (mmol/L) | 3.81±0.99 | 4.41±0.73 | 0.0001 |
Triglyceride (mmol/L) | 1.51±0.72 | 1.11±0.32 | 0.0001 |
HDL-cholesterol (mmol/L) | 0.99±0.27 | 1.20±0.26 | 0.0001 |
LDL-cholesterol (mmol/L) | 2.87±0.54 | 2.41±0.77 | 0.0001 |
Homocycteine (mmol/L) | 20.59±12.29 | 14.44±4.59 | 0.001 |
Myeloperoxidase (mmol/L) | 1014±325 | 585±324 | 0.0001 |
Uric Acid (mmol/L) | 347.77±88.18 | 299.19±54.26 | 0.001 |